Literature DB >> 14733830

Heat shock-peptide complex vaccine as adjuvant therapy for high-risk patients with resected renal cell carcinoma.

Oleg Shvarts, John Lam, Robert Figlin, Arie S Belldegrun.   

Abstract

Entities:  

Year:  2004        PMID： 14733830     DOI： 10.1007/s11934-004-0004-z

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


× No keyword cloud information.
  12 in total

1.  Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations.

Authors:  Y Tamura; P Peng; K Liu; M Daou; P K Srivastava
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

2.  Preventive and therapeutic effect of tumor derived heat shock protein, gp96, in an experimental prostate cancer model.

Authors:  S P Yedavelli; L Guo; M E Daou; P K Srivastava; A Mittelman; R K Tiwari
Journal:  Int J Mol Med       Date:  1999-09       Impact factor: 4.101

3.  Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

Authors:  R J Motzer; M Mazumdar; J Bacik; W Berg; A Amsterdam; J Ferrara
Journal:  J Clin Oncol       Date:  1999-08       Impact factor: 44.544

4.  Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity.

Authors:  X Y Wang; L Kazim; E A Repasky; J R Subjeck
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

Review 5.  Biochemical, cell biological and immunological issues surrounding the endoplasmic reticulum chaperone GRP94/gp96.

Authors:  C V Nicchitta
Journal:  Curr Opin Immunol       Date:  1998-02       Impact factor: 7.486

6.  Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial.

Authors:  Joseph I Clark; Michael B Atkins; Walter J Urba; Steven Creech; Robert A Figlin; Janice P Dutcher; Larry Flaherty; Jeffrey A Sosman; Theodore F Logan; Richard White; Geoffrey R Weiss; Bruce G Redman; Christopher P G Tretter; David McDermott; John W Smith; Michael S Gordon; Kim A Margolin
Journal:  J Clin Oncol       Date:  2003-06-16       Impact factor: 44.544

7.  Cancer statistics, 2003.

Authors:  Ahmedin Jemal; Taylor Murray; Alicia Samuels; Asma Ghafoor; Elizabeth Ward; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2003 Jan-Feb       Impact factor: 508.702

8.  Tumor rejection antigens of chemically induced sarcomas of inbred mice.

Authors:  P K Srivastava; A B DeLeo; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

9.  Generation of tumor-specific cytotoxic T lymphocytes and memory T cells by immunization with tumor-derived heat shock protein gp96.

Authors:  S Janetzki; N E Blachere; P K Srivastava
Journal:  J Immunother       Date:  1998-07       Impact factor: 4.456

Review 10.  Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications.

Authors:  Axel Hoos; Daniel L Levey
Journal:  Expert Rev Vaccines       Date:  2003-06       Impact factor: 5.217
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.